We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 961 results
  1. HIV-1 infection of renal epithelial cells: 30 years of evidence from transgenic animal models, human studies and in vitro experiments

    Although antiretroviral therapy (ART) has increased life expectancy in people with HIV-1 (PWH), acute and chronic kidney disease remain common in...

    Maria Blasi, Mary Klotman in Retrovirology
    Article Open access 16 March 2023
  2. Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice

    HIV-1 reservoirs persist in the presence of combined antiretroviral therapy (cART). However, cART has transformed HIV-1 infection into a chronic...

    Matthew Weichseldorfer, Yvonne Affram, ... Olga S. Latinovic in Journal of Translational Medicine
    Article Open access 30 October 2021
  3. Inactivation of cell-free HIV-1 by designing potent peptides based on mutations in the CD4 binding site

    Human immunodeficiency virus type 1 (HIV-1) is a major global health problem, with over 38 million people infected worldwide. Current anti-HIV-1...

    Fatemeh Sabzian-Molaei, Mohammad Amin Ahmadi, ... Mohammad Sabzian-Molaei in Medical & Biological Engineering & Computing
    Article 27 October 2023
  4. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice

    Opioid overdose deaths have dramatically increased by 781% from 1999 to 2021. In the setting of HIV, opioid drug abuse exacerbates neurotoxic effects...

    Kara M. Rademeyer, Sara R. Nass, ... MaryPeace McRae in Journal of NeuroVirology
    Article 27 January 2024
  5. DNA topoisomerase 1 represses HIV-1 promoter activity through its interaction with a guanine quadruplex present in the LTR sequence

    Background

    Once integrated in the genome of infected cells, HIV-1 provirus is transcribed by the cellular transcription machinery. This process is...

    María José Lista, Anne-Caroline Jousset, ... Marc Lavigne in Retrovirology
    Article Open access 30 May 2023
  6. Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

    There is no cure for HIV infection, and lifelong antiretroviral therapy (ART) is required. N-803 is an IL-15 superagonist comprised of an N72D mutant...

    Jeffrey S. Miller, Zachary B. Davis, ... Timothy W. Schacker in Nature Medicine
    Article 31 January 2022
  7. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection

    Integrase strand transfer inhibitors (INSTIs) have improved the treatment of human immunodeficiency virus (HIV). There are currently four approved...

    Alexa Vyain Zhao, Rustin D. Crutchley, ... Amy Cheng Min in Retrovirology
    Article Open access 22 October 2022
  8. Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology

    Whether the human brain is a robust reservoir for HIV-1 subtype C has yet to be established. We aimed to determine whether HIV-1 subtype C infection...

    Jane Musumali, Peter Julius, ... Charles Wood in Journal of NeuroVirology
    Article 05 October 2022
  9. Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

    HIVACAT T-cell immunogen (HTI) is a novel human immunodeficiency virus (HIV) vaccine immunogen designed to elicit cellular immune responses to HIV...

    Lucia Bailón, Anuska Llano, ... Jordi Puig in Nature Medicine
    Article 27 October 2022
  10. The CREB Regulated Transcription Coactivator 2 Suppresses HIV-1 Transcription by Preventing RNA Pol II from Binding to HIV-1 LTR

    The CREB-regulated transcriptional co-activators (CRTCs), including CRTC1, CRTC2 and CRTC3, enhance transcription of CREB-targeted genes. In addition...

    Ling Ma, Shumin Chen, ... Shan Cen in Virologica Sinica
    Article 15 March 2021
  11. Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

    Attempts to reduce the human immunodeficiency virus type 1 (HIV-1) reservoir and induce antiretroviral therapy (ART)-free virologic control have...

    Jesper D. Gunst, Marie H. Pahus, ... Ole S. Søgaard in Nature Medicine
    Article 17 October 2022
  12. The forces driving clonal expansion of the HIV-1 latent reservoir

    Despite antiretroviral therapy (ART) which halts HIV-1 replication and reduces plasma viral load to clinically undetectable levels, viral rebound...

    Runxia Liu, Francesco R. Simonetti, Ya-Chi Ho in Virology Journal
    Article Open access 07 January 2020
  13. Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir

    The "Shock and Kill" method is being considered as a potential treatment for eradicating HIV-1 and achieving a functional cure for acquired...

    Zhujiao Zhou, Yashuang Jiang, ... Geng Yang in Archives of Virology
    Article 29 November 2023
  14. AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques

    The main barrier to HIV cure is a persistent reservoir of latently infected CD4 + T cells harboring replication-competent provirus that fuels rebound...

    Amir Dashti, Sophia Sukkestad, ... Ann Chahroudi in Nature Medicine
    Article Open access 02 October 2023
  15. Caffeine upregulates SIRT3 expression to ameliorate astrocytes-mediated HIV-1 Tat neurotoxicity via suppression of EGR1 signaling pathway

    Caffeine is one of the most popular consumed psychostimulants that mitigates several neurodegenerative diseases. Nevertheless, the roles and...

    Lin Gao, Weixi Sun, ... Dongmei Zhang in Journal of NeuroVirology
    Article 26 June 2024
  16. Extracellular vesicles produced by HIV-1 Nef-expressing cells induce myelin impairment and oligodendrocyte damage in the mouse central nervous system

    HIV-associated neurocognitive disorders (HAND) are a spectrum of cognitive impairments that continue to affect approximately half of all HIV-positive...

    Jessica K. Schenck, Molly T. Karl, ... Michael I. Bukrinsky in Journal of Neuroinflammation
    Article Open access 13 May 2024
  17. A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis

    Background

    Although macrophages are now recognized as an essential part of the HIV latent reservoir, whether and how viral latency is established and...

    Javan K. Kisaka, Daniel Rauch, ... George B. Kyei in Virology Journal
    Article Open access 05 April 2024
  18. HIV-1 subtype B Tat enhances NOTCH3 signaling in astrocytes to mediate oxidative stress, inflammatory response, and neuronal apoptosis

    NOTCH receptors are relevant to multiple neurodegenerative diseases. However, the roles and mechanisms of NOTCH receptors in HIV-associated...

    Lin Gao, Weixi Sun, ... Hongbin Liu in Journal of NeuroVirology
    Article 26 June 2023
  19. Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir

    Understanding the complexity of the long-lived HIV reservoir during antiretroviral therapy (ART) remains a considerable impediment in research...

    Vincent H. Wu, Jayme M. L. Nordin, ... Michael R. Betts in Nature Immunology
    Article Open access 19 December 2022
Did you find what you were looking for? Share feedback.